SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • December 16th, 2016 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
This Securities Exchange Agreement (this “Agreement”) is dated as of December 16, 2016, between Microbot Medical Inc. (f/k/a Stemcells, Inc.), a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
